Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 10.4B | 11.0B | 10.6B | 10.4B |
| Cost of revenue | 4.5B | 4.9B | 4.7B | 4.6B |
| Gross profit | 5.9B | 6.0B | 5.9B | 5.8B |
| Operating expense | ||||
| Research & development | 716M | 749M | 713M | 698M |
| Selling general and admin | 3.1B | 2.9B | 2.9B | 2.9B |
| Other operating expenses | — | — | — | — |
| Operating income | 1.7B | 1.9B | 1.9B | 1.7B |
| Non operating interest income | ||||
| Income | 82M | 91M | 91M | 82M |
| Expense | 131M | 136M | 142M | 140M |
| Other income expense | 134M | 164M | 132M | -4M |
| Pretax income | 1.8B | 2.0B | 1.9B | 1.6B |
| Tax provision | 453M | -7.2B | 294M | 305M |
| Net income | 1.3B | 9.2B | 1.6B | 1.3B |
| Basic EPS | — | 10.7 | 1.9 | 1.5 |
| Diluted EPS | — | 10.5 | 1.9 | 1.5 |
| Basic average shares | — | 739.7K | 740.9K | 743.2K |
| Diluted average shares | — | 745.8K | 746.7K | 748.0K |
| EBITDA | 2.7B | 3.0B | 2.9B | 2.5B |
| Net income from continuing op. | 1.3B | 9.2B | 1.6B | 1.3B |
| Minority interests | — | — | — | — |
| Preferred stock dividends | — | — | — | — |